Progress in the Treatment of Acquired Hemophilia A
10.3969/j.issn.1003-4706.2018.05.026
- VernacularTitle:获得性血友病A的治疗进展
- Author:
Huan LIN
1
;
Cheng-Ping LI
;
Bing-Fen WU
;
Li RAN
Author Information
1. 昆明医科大学第一附属医院
- Keywords:
Acquired hemophilia A;
Coagulation factor;
Treatment
- From:
Journal of Kunming Medical University
2018;39(5):128-131
- CountryChina
- Language:Chinese
-
Abstract:
Acquired hemophilia A is a deficiency disease caused by blood coagulation factor Ⅷ antibodies due to a variety of causes, The disease incidence rate is extremely low, but the mortality rate is high. This disease is often misdiagnosed,resulting in delays in treatment, so early diagnosis and timely treatment is crucial for reducing the mortality. The principle of treatment for the disease is mainly to control acute bleeding, eradicate inhibitor, and treat the primary disease,therefore, rational and personalized choices of treatment are also critical.
